{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:11:04Z","timestamp":1793747464982,"version":"4.6.1"},"publisher-location":"Singapore","reference-count":111,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811388705","type":"print"},{"value":"9789811388712","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-981-13-8871-2_15","type":"book-chapter","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T03:02:58Z","timestamp":1565319778000},"page":"325-346","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Role of Aldosterone in Renal Fibrosis"],"prefix":"10.1007","author":[{"given":"Aanchal","family":"Shrestha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Chen","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,9]]},"reference":[{"key":"15_CR1","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.yexcr.2012.02.025","volume":"318","author":"HE Abboud","year":"2012","unstructured":"Abboud HE (2012) Mesangial cell biology. Exp Cell Res 318:979\u2013985","journal-title":"Exp Cell Res"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1172\/JCI38019","volume":"119","author":"H Acloque","year":"2009","unstructured":"Acloque H, Adams MS, Fishwick K, Bronner-Fraser M, Nieto MA (2009) Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 119:1438\u20131449","journal-title":"J Clin Invest"},{"key":"15_CR3","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1097\/01.ASN.0000083982.74108.54","volume":"14","author":"S Arima","year":"2003","unstructured":"Arima S, Kohagura K, Xu H-L, Sugawara A, Abe T, Satoh F et al (2003) Nongenomic vascular action of aldosterone in the glomerular microcirculation. J Am Soc Nephrol 14:2255\u20132263","journal-title":"J Am Soc Nephrol"},{"key":"15_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1126\/science.3037703","volume":"237","author":"JL Arriza","year":"1987","unstructured":"Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE et al (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268\u2013275","journal-title":"Science"},{"key":"15_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/ndt\/gfs388","volume":"28","author":"M Azizi","year":"2012","unstructured":"Azizi M, Amar L, Menard J (2012) Aldosterone synthase inhibition in humans. Nephrol Dial Transplant 28:36\u201343","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.iy.12.040194.001041","volume":"12","author":"PA Baeuerle","year":"1994","unstructured":"Baeuerle PA, Henkel T (1994) Function and activation of NF-kappaB in the immune system. Annu Rev Immunol 12:141\u2013179","journal-title":"Annu Rev Immunol"},{"key":"15_CR7","doi-asserted-by":"publisher","first-page":"F556","DOI":"10.1152\/ajprenal.00332.2016","volume":"312","author":"M Bai","year":"2017","unstructured":"Bai M, Chen Y, Zhao M, Zhang Y, He JC-J, Huang S et al (2017) NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury. Am J Physiol Renal Physiol 312:F556\u2013F564","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR8","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1001\/jama.2015.10081","volume":"314","author":"GL Bakris","year":"2015","unstructured":"Bakris GL, Agarwal R, Chan JC, Cooper ME, Gansevoort RT, Haller H et al (2015) Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial. JAMA 314:884\u2013894","journal-title":"JAMA"},{"key":"15_CR9","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","volume":"70","author":"S Bianchi","year":"2006","unstructured":"Bianchi S, Bigazzi R, Campese VM (2006) Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease. Kidney Int 70:2116\u20132123","journal-title":"Kidney Int"},{"key":"15_CR10","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","volume":"63","author":"ER Blasi","year":"2003","unstructured":"Blasi ER, Rocha R, Rudolph AE, Blomme EA, Polly ML, McMahon EG (2003) Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int 63:1791\u20131800","journal-title":"Kidney Int"},{"key":"15_CR11","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1093\/ndt\/gfg265","volume":"18","author":"B Boldyreff","year":"2003","unstructured":"Boldyreff B, Wehling M (2003) Non-genomic actions of aldosterone: mechanisms and consequences in kidney cells. Nephrol Dial Transplant 18:1693\u20131695","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"AS Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ (2007) The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 3:486\u2013492","journal-title":"Nat Clin Pract Nephrol"},{"key":"15_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/eurheartj\/16.suppl_N.92","volume":"16","author":"J Bonvalet","year":"1995","unstructured":"Bonvalet J, Alfaidy N, Farman N, Lombes M (1995) Aldosterone: intracellular receptors in human heart. Eur Heart J 16:92\u201397","journal-title":"Eur Heart J"},{"key":"15_CR14","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrneph.2013.110","volume":"9","author":"NJ Brown","year":"2013","unstructured":"Brown NJ (2013) Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis. Nat Rev Nephrol 9:459\u2013469","journal-title":"Nat Rev Nephrol"},{"key":"15_CR15","first-page":"336","volume":"85","author":"NJ Brown","year":"2000","unstructured":"Brown NJ, Kim KS, Chen YQ, Blevins LS, Nadeau JH, Meranze SG et al (2000a) Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production. J Clin Endocrinol Metab 85:336\u2013344","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR16","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","volume":"58","author":"NJ Brown","year":"2000","unstructured":"Brown NJ, Nakamura S, Ma L, Nakamura I, Donnert E, Freeman M et al (2000b) Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo. Kidney Int 58:1219\u20131227","journal-title":"Kidney Int"},{"key":"15_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1471-2369-13-70","volume":"13","author":"EW Brunskill","year":"2012","unstructured":"Brunskill EW, Potter SS (2012) Changes in the gene expression programs of renal mesangial cells during diabetic nephropathy. BMC Nephrol 13:70","journal-title":"BMC Nephrol"},{"key":"15_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1159\/000320359","volume":"193","author":"W Burns","year":"2011","unstructured":"Burns W, Thomas M (2011) Angiotensin II and its role in tubular epithelial to mesenchymal transition associated with chronic kidney disease. Cells Tissues Organs 193:74\u201384","journal-title":"Cells Tissues Organs"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1159\/000228080","volume":"113","author":"C Chen","year":"2009","unstructured":"Chen C, Liang W, Jia J, Van Goor H, Singhal PC, Ding G (2009) Aldosterone induces apoptosis in rat podocytes: role of PI3-K\/Akt and p38MAPK signaling pathways. Nephron Exp Nephrol 113:e26\u2013e34","journal-title":"Nephron Exp Nephrol"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0039-128X(98)00103-2","volume":"64","author":"M Christ","year":"1999","unstructured":"Christ M, Wehling M (1999) Rapid actions of aldosterone: lymphocytes, vascular smooth muscle and endothelial cells. Steroids 64:35\u201341","journal-title":"Steroids"},{"key":"15_CR21","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2215\/CJN.01040905","volume":"1","author":"A Chrysostomou","year":"2006","unstructured":"Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ (2006) Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Clin J Am Soc Nephrol 1:256\u2013262","journal-title":"Clin J Am Soc Nephrol"},{"key":"15_CR22","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/S0735-1097(01)01237-2","volume":"37","author":"M Cicoira","year":"2001","unstructured":"Cicoira M, Zanolla L, Rossi A, Golia G, Franceschini L, Cabrini G et al (2001) Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. J Am Coll Cardiol 37:1808\u20131812","journal-title":"J Am Coll Cardiol"},{"key":"15_CR23","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/0006-8993(85)91291-0","volume":"361","author":"H Coirini","year":"1985","unstructured":"Coirini H, Mari A, De Nicola AF, Rainbow TC, McEwen BS (1985) Further studies of brain aldosterone binding sites employing new mineralocorticoid and glucocorticoid receptor markers in vitro. Brain Res 361:212\u2013216","journal-title":"Brain Res"},{"key":"15_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/0002-9610(64)90252-1","volume":"107","author":"JW Conn","year":"1964","unstructured":"Conn JW, Knopf RF, Nesbit RM (1964) Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am J Surg 107:159\u2013172","journal-title":"Am J Surg"},{"key":"15_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.lfs.2012.02.022","volume":"90","author":"W Ding","year":"2012","unstructured":"Ding W, Yang L, Zhang M, Gu Y (2012) Chronic inhibition of nuclear factor kappa B attenuates aldosterone\/salt-induced renal injury. Life Sci 90:600\u2013666","journal-title":"Life Sci"},{"key":"15_CR26","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.amjmed.2006.03.038","volume":"119","author":"M Epstein","year":"2006","unstructured":"Epstein M (2006) Aldosterone blockade: an emerging strategy for abrogating progressive renal disease. Am J Med 119:912\u2013919","journal-title":"Am J Med"},{"key":"15_CR27","doi-asserted-by":"publisher","first-page":"F181","DOI":"10.1152\/ajprenal.2001.280.2.F181","volume":"280","author":"N Farman","year":"2001","unstructured":"Farman N, Rafestin-Oblin M-E (2001) Multiple aspects of mineralocorticoid selectivity. Am J Physiol Renal Physiol 280:F181\u2013F192","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1146\/annurev-pharmtox-070115-095427","volume":"56","author":"SJ Forrester","year":"2016","unstructured":"Forrester SJ, Kawai T, O\u2019Brien S, Thomas W, Harris RC, Eguchi S (2016) Epidermal growth factor receptor transactivation: mechanisms, pathophysiology, and potential therapies in the cardiovascular system. Annu Rev Pharmacol Toxicol 56:627\u2013653","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"15_CR29","doi-asserted-by":"publisher","first-page":"5264","DOI":"10.1210\/endo.137.12.8940344","volume":"137","author":"Funder J, Myles K","year":"1996","unstructured":"Funder J, Myles K (1996) Exclusion of corticosterone from epithelial mineralocorticoid receptors is insufficient for selectivity of aldosterone action: in vivo binding studies. Endocrinology 137:5264\u20135268","journal-title":"Endocrinology"},{"key":"15_CR30","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.pcad.2009.12.003","volume":"52","author":"Funder JW","year":"2010","unstructured":"Funder JW (2010) Aldosterone and mineralocorticoid receptors in the cardiovascular system. Prog Cardiovasc Dis 52:393\u2013400","journal-title":"Prog Cardiovasc Dis"},{"key":"15_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1126\/science.2845584","volume":"242","author":"Funder JW, Pearce PT, Smith R, Smith AI","year":"1988","unstructured":"Funder JW, Pearce PT, Smith R, Smith AI (1988) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583\u2013585","journal-title":"Science"},{"key":"15_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1291\/hypres.31.59","volume":"31","author":"Y Furumatsu","year":"2008","unstructured":"Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N et al (2008) Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker. Hypertens Res 31:59\u201367","journal-title":"Hypertens Res"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1093\/ndt\/gfm410","volume":"22","author":"S Gauer","year":"2007","unstructured":"Gauer S, Segitz V, Goppelt-Struebe M (2007) Aldosterone induces CTGF in mesangial cells by activation of the glucocorticoid receptor. Nephrol Dial Transplant 22:3154\u20133159","journal-title":"Nephrol Dial Transplant"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0025-7125(03)00125-1","volume":"88","author":"A Gonzalez","year":"2004","unstructured":"Gonzalez A, L\u00f3pez B, D\u0131\u0301ez J (2004) Fibrosis in hypertensive heart disease: role of the renin-angiotensin-aldosterone system. Med Clin North Am 88:83\u201397","journal-title":"Med Clin North Am"},{"key":"15_CR35","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1172\/JCI118867","volume":"98","author":"E Greene","year":"1996","unstructured":"Greene E, Kren S, Hostetter T (1996) Role of aldosterone in the remnant kidney model in the rat. J Clin Invest 98:1063\u20131068","journal-title":"J Clin Invest"},{"key":"15_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/HYPERTENSIONAHA.110.161653","volume":"57","author":"R Gros","year":"2011","unstructured":"Gros R, Ding Q, Sklar LA, Prossnitz EE, Arterburn JB, Chorazyczewski J et al (2011) GPR30 expression is required for the mineralocorticoid receptor\u2013independent rapid vascular effects of aldosterone. Hypertension 57:442\u2013451","journal-title":"Hypertension"},{"key":"15_CR37","doi-asserted-by":"publisher","first-page":"C532","DOI":"10.1152\/ajpcell.00203.2012","volume":"304","author":"R Gros","year":"2013","unstructured":"Gros R, Ding Q, Liu B, Chorazyczewski J, Feldman RD (2013) Aldosterone mediates its rapid effects in vascular endothelial cells through GPER activation. Am J Physiol Cell Physiol 304:C532\u2013C540","journal-title":"Am J Physiol Cell Physiol"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"E1790","DOI":"10.1152\/ajpendo.00708.2006","volume":"292","author":"C Grossmann","year":"2007","unstructured":"Grossmann C, Krug AW, Freudinger R, Mildenberger S, Voelker K, Gekle M (2007) Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter. Am J Physiol Endocrinol Metab 292:E1790\u2013E1800","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"15_CR39","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/sj.ki.5000438","volume":"70","author":"K Han","year":"2006","unstructured":"Han K, Kang Y, Han SY, Jee Y, Lee M, Han J et al (2006) Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats. Kidney Int 70:111\u2013120","journal-title":"Kidney Int"},{"key":"15_CR40","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.3346\/jkms.2009.24.S1.S195","volume":"24","author":"JS Han","year":"2009","unstructured":"Han JS, Choi BS, Yang CW, Kim YS (2009) Aldosterone-induced TGF-\u03b21 expression is regulated by mitogen-activated protein kinases and activator protein-1 in mesangial cells. J Korean Med Sci 24:S195\u2013S203","journal-title":"J Korean Med Sci"},{"key":"15_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00467-017-3883-1","volume":"34","author":"HI Han","year":"2019","unstructured":"Han HI, Skvarca LB, Espiritu EB, Davidson AJ, Hukriede NA (2019) The role of macrophages during acute kidney injury: destruction and repair. Pediatr Nephrol 34:1\u20139","journal-title":"Pediatr Nephrol"},{"key":"15_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1177\/1470320313519486","volume":"16","author":"J Hao","year":"2015","unstructured":"Hao J, Ren L, Zhang L, Kong D, Hao L (2015) Aldosterone-induced inflammatory response of mesangial cells via angiotension II receptors. J Renin Angiotensin Aldosterone Syst 16:739\u2013748","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"15_CR43","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1089\/ten.2006.0199","volume":"13","author":"S Heber","year":"2007","unstructured":"Heber S, Denk L, Hu K, Minuth WW (2007) Modulating the development of renal tubules growing in serum-free culture medium at an artificial interstitium. Tissue Eng 13:281\u2013292","journal-title":"Tissue Eng"},{"key":"15_CR44","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1097\/01.ASN.0000086472.65806.73","volume":"14","author":"TH Hostetter","year":"2003","unstructured":"Hostetter TH, Ibrahim HN (2003) Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol 14:2395\u20132401","journal-title":"J Am Soc Nephrol"},{"key":"15_CR45","doi-asserted-by":"publisher","first-page":"F1287","DOI":"10.1152\/ajprenal.00017.2008","volume":"294","author":"W Huang","year":"2008","unstructured":"Huang W, Xu C, Kahng KW, Noble NA, Border WA, Huang Y (2008) Aldosterone and TGF-\u03b21 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells. Am J Physiol Renal Physiol 294:F1287\u2013F1295","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR46","doi-asserted-by":"publisher","first-page":"F1323","DOI":"10.1152\/ajprenal.90428.2008","volume":"296","author":"S Huang","year":"2009","unstructured":"Huang S, Zhang A, Ding G, Chen R (2009) Aldosterone-induced mesangial cell proliferation is mediated by EGF receptor transactivation. Am J Physiol Renal Physiol 296:F1323\u2013F1333","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR47","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1159\/000339500","volume":"120","author":"L Huang","year":"2012","unstructured":"Huang L, Nikolic-Paterson D, Ma F, Tesch G (2012) Aldosterone induces kidney fibroblast proliferation via activation of growth factor receptors and PI3K\/MAPK signalling. Nephron Exp Nephrol 120:e115\u2013e122","journal-title":"Nephron Exp Nephrol"},{"key":"15_CR48","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ki.2008.507","volume":"75","author":"H Ikeda","year":"2009","unstructured":"Ikeda H, Tsuruya K, Toyonaga J, Masutani K, Hayashida H, Hirakata H et al (2009) Spironolactone suppresses inflammation and prevents L-NAME\u2013induced renal injury in rats. Kidney Int 75:147\u2013155","journal-title":"Kidney Int"},{"key":"15_CR49","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1161\/HYPERTENSIONAHA.107.102640","volume":"51","author":"J Irita","year":"2008","unstructured":"Irita J, Okura T, Kurata M, Miyoshi K-i, Fukuoka T, Higaki J (2008) Osteopontin in rat renal fibroblasts: functional properties and transcriptional regulation by aldosterone. Hypertension 51:507\u2013513","journal-title":"Hypertension"},{"key":"15_CR50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1124\/pr.115.011106","volume":"68","author":"F Jaisser","year":"2016","unstructured":"Jaisser F, Farman N (2016) Emerging roles of the mineralocorticoid receptor in pathology: toward new paradigms in clinical pharmacology. Pharmacol Rev 68:49\u201375","journal-title":"Pharmacol Rev"},{"key":"15_CR51","doi-asserted-by":"publisher","first-page":"F1059","DOI":"10.1152\/ajprenal.00202.2003","volume":"286","author":"I Juknevicius","year":"2004","unstructured":"Juknevicius I, Segal Y, Kren S, Lee R, Hostetter TH (2004) Effect of aldosterone on renal transforming growth factor-\u03b2. Am J Physiol Renal Physiol 286:F1059\u2013F1062","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR52","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119:1420\u20131428","journal-title":"J Clin Invest"},{"key":"15_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1254\/jphs.08R02CR","volume":"108","author":"H Kiyomoto","year":"2008","unstructured":"Kiyomoto H, Rafiq K, Mostofa M, Nishiyama A (2008) Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. J Pharmacol Sci 108:399\u2013405","journal-title":"J Pharmacol Sci"},{"key":"15_CR54","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.mce.2011.06.025","volume":"350","author":"P Kolkhof","year":"2012","unstructured":"Kolkhof P, Borden SA (2012) Molecular pharmacology of the mineralocorticoid receptor: prospects for novel therapeutics. Mol Cell Endocrinol 350:310\u2013317","journal-title":"Mol Cell Endocrinol"},{"key":"15_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/ajh\/7.1.100","volume":"7","author":"L Kornel","year":"1994","unstructured":"Kornel L (1994) Colocalization of 11\u03b2-hydroxysteroid dehydrogenase and mineralocorticoid receptors in cultured vascular smooth muscle cells. Am J Hypertens 7:100\u2013103","journal-title":"Am J Hypertens"},{"key":"15_CR56","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1161\/HYPERTENSIONAHA.107.100438","volume":"50","author":"L Lenzini","year":"2007","unstructured":"Lenzini L, Seccia TM, Aldighieri E, Belloni AS, Bernante P, Giuliani L et al (2007) Heterogeneity of aldosterone-producing adenomas revealed by a whole transcriptome analysis. Hypertension 50:1106\u20131113","journal-title":"Hypertension"},{"key":"15_CR57","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1159\/000430106","volume":"36","author":"C Li","year":"2015","unstructured":"Li C, Ding XY, Xiang DM, Xu J, Huang XL, Hou FF et al (2015) Enhanced M1 and impaired M2 macrophage polarization and reduced mitochondrial biogenesis via inhibition of AMP kinase in chronic kidney disease. Cell Physiol Biochem 36:358\u2013372","journal-title":"Cell Physiol Biochem"},{"key":"15_CR58","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/nrneph.2011.149","volume":"7","author":"Y Liu","year":"2011","unstructured":"Liu Y (2011) Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7:684\u2013696","journal-title":"Nat Rev Nephrol"},{"key":"15_CR59","doi-asserted-by":"publisher","first-page":"e0145946","DOI":"10.1371\/journal.pone.0145946","volume":"11","author":"B Mart\u00edn-Fern\u00e1ndez","year":"2016","unstructured":"Mart\u00edn-Fern\u00e1ndez B, Rubio-Navarro A, Cortegano I, Ballesteros S, Al\u00eda M, Cannata-Ortiz P et al (2016) Aldosterone induces renal fibrosis and inflammatory M1-macrophage subtype via mineralocorticoid receptor in rats. PLoS ONE 11:e0145946","journal-title":"PLoS ONE"},{"key":"15_CR60","doi-asserted-by":"publisher","first-page":"F73","DOI":"10.1152\/ajprenal.00435.2007","volume":"295","author":"JT Mathew","year":"2008","unstructured":"Mathew JT, Patni H, Chaudhary AN, Liang W, Gupta A, Chander PN et al (2008) Aldosterone induces mesangial cell apoptosis both in vivo and in vitro. Am J Physiol Renal Physiol 295:F73\u2013F81","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR61","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.steroids.2005.02.004","volume":"70","author":"Mihailidou AS, Funder JW","year":"2005","unstructured":"Mihailidou AS, Funder JW (2005) Nongenomic effects of mineralocorticoid receptor activation in the cardiovascular system. Steroids 70:347\u2013351","journal-title":"Steroids"},{"key":"15_CR62","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/01.RES.0000180753.63183.95","volume":"97","author":"LJ Min","year":"2005","unstructured":"Min LJ, Mogi M, Li JM, Iwanami J, Iwai M, Horiuchi M (2005) Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells. Circ Res 97:434\u2013442","journal-title":"Circ Res"},{"key":"15_CR63","doi-asserted-by":"publisher","first-page":"6588","DOI":"10.1016\/j.biomaterials.2005.04.029","volume":"26","author":"WW Minuth","year":"2005","unstructured":"Minuth WW, Denk L, Heber S (2005) Growth of embryonic renal parenchyme at the interphase of a polyester artificial interstitium. Biomaterials 26:6588\u20136598","journal-title":"Biomaterials"},{"key":"15_CR64","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1681\/ASN.2005040390","volume":"16","author":"K Miyata","year":"2005","unstructured":"Miyata K, Rahman M, Shokoji T, Nagai Y, Zhang GX, Sun GP et al (2005) Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells. J Am Soc Nephrol 16:2906\u20132912","journal-title":"J Am Soc Nephrol"},{"key":"15_CR65","doi-asserted-by":"publisher","first-page":"783538","DOI":"10.1155\/2015\/783538","volume":"2015","author":"JL Morgado-Pascual","year":"2015","unstructured":"Morgado-Pascual JL, Rayego-Mateos S, Valdivielso JM, Ortiz A, Egido J, Ruiz-Ortega M (2015) Paricalcitol inhibits aldosterone-induced proinflammatory factors by modulating epidermal growth factor receptor pathway in cultured tubular epithelial cells. Biomed Res Int 2015:783538","journal-title":"Biomed Res Int"},{"key":"15_CR66","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1161\/01.HYP.0000222003.28517.99","volume":"47","author":"M Nagase","year":"2006","unstructured":"Nagase M, Shibata S, Yoshida S, Nagase T, Gotoda T, Fujita T (2006) Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 47:1084\u20131093","journal-title":"Hypertension"},{"key":"15_CR67","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/HYPERTENSIONAHA.107.091058","volume":"50","author":"M Nagase","year":"2007","unstructured":"Nagase M, Matsui H, Shibata S, Gotoda T, Fujita T (2007) Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress. Hypertension 50:877\u2013883","journal-title":"Hypertension"},{"issue":"1","key":"15_CR68","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/01.HYP.0000022606.52221.2F","volume":"40","author":"M Naruse","year":"2002","unstructured":"Naruse M, Tanabe A, Sato A, Takagi S, Tsuchiya K, Imaki T et al (2002) Aldosterone breakthrough during angiotensin II receptor antagonist therapy in stroke-prone spontaneously hypertensive rats. Hypertension 40(1):28\u201333","journal-title":"Hypertension"},{"key":"15_CR69","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/01.HYP.0000118519.66430.22","volume":"43","author":"A Nishiyama","year":"2004","unstructured":"Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S et al (2004) Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone\/salt-induced hypertensive rats. Hypertension 43:841\u2013848","journal-title":"Hypertension"},{"key":"15_CR70","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1161\/01.HYP.0000154681.38944.9a","volume":"45","author":"A Nishiyama","year":"2005","unstructured":"Nishiyama A, Yao L, Fan Y, Kyaw M, Kataoka N, Hashimoto K et al (2005) Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Hypertension 45:710\u2013716","journal-title":"Hypertension"},{"key":"15_CR71","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1124\/jpet.109.158113","volume":"332","author":"A Nishiyama","year":"2010","unstructured":"Nishiyama A, Kobori H, Konishi Y, Morikawa T, Maeda I, Okumura M et al (2010) Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. J Pharmacol Exp Ther 332:1072\u20131080","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR72","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00020.2002","volume":"83","author":"H Pavenstadt","year":"2003","unstructured":"Pavenstadt H, Kriz W, Kretzler M (2003) Cell biology of the glomerular podocyte. Physiol Rev 83:253\u2013307","journal-title":"Physiol Rev"},{"key":"15_CR73","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1159\/000262316","volume":"114","author":"MK Phanish","year":"2010","unstructured":"Phanish MK, Winn S, Dockrell M (2010) Connective tissue growth factor-(CTGF, CCN2)\u2013a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 114:e83\u2013e92","journal-title":"Nephron Exp Nephrol"},{"key":"15_CR74","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 341:709\u2013717","journal-title":"N Engl J Med"},{"key":"15_CR75","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.778811","volume":"118","author":"B Pitt","year":"2008","unstructured":"Pitt B, Bakris G, Ruilope LM, DiCarlo L, Mukherjee R (2008) Serum potassium and clinical outcomes in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation 118:1643\u20131650","journal-title":"Circulation"},{"key":"15_CR76","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","volume":"34","author":"B Pitt","year":"2013","unstructured":"Pitt B, Kober L, Ponikowski P, Gheorghiade M, Filippatos G, Krum H et al (2013) Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial. Eur Heart J 34:2453\u20132463","journal-title":"Eur Heart J"},{"key":"15_CR77","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1172\/JCI104946","volume":"43","author":"GA Porter","year":"1964","unstructured":"Porter GA, Edelman IS (1964) The action of aldosterone and related corticosteroids on sodium transport across the toad bladder. J Clin Invest 43:611\u2013620","journal-title":"J Clin Invest"},{"key":"15_CR78","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1073\/pnas.52.6.1326","volume":"52","author":"GA Porter","year":"1964","unstructured":"Porter GA, Bogoroch R, Edelman IS (1964) On the mechanism of action of aldosterone on sodium transport: the role of RNA synthesis. Proc Natl Acad Sci U S A 52:1326\u20131333","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15_CR79","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0039-128X(99)00087-2","volume":"65","author":"FM Rogerson","year":"2000","unstructured":"Rogerson FM, Fuller PJ (2000) Mineralocorticoid action. Steroids 65:61\u201373","journal-title":"Steroids"},{"key":"15_CR80","doi-asserted-by":"publisher","first-page":"2985","DOI":"10.1681\/ASN.2006040356","volume":"17","author":"C R\u00fcster","year":"2006","unstructured":"R\u00fcster C, Wolf G (2006) Renin-angiotensin-aldosterone system and progression of renal disease. J Am Soc Nephrol 17:2985\u20132991","journal-title":"J Am Soc Nephrol"},{"key":"15_CR81","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/hr.2013.74","volume":"36","author":"A Sato","year":"2013","unstructured":"Sato A, Fukuda S (2013) Effect of aldosterone breakthrough on albuminuria during treatment with a direct renin inhibitor and combined effect with a mineralocorticoid receptor antagonist. Hypertens Res 36:879\u2013884","journal-title":"Hypertens Res"},{"key":"15_CR82","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1007\/s00125-004-1542-0","volume":"47","author":"K Schjoedt","year":"2004","unstructured":"Schjoedt K, Andersen S, Rossing P, Tarnow L, Parving H-H (2004) Aldosterone escape during blockade of the renin\u2013angiotensin\u2013aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 47:1936\u20131939","journal-title":"Diabetologia"},{"key":"15_CR83","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/sj.ki.5001580","volume":"70","author":"K Schjoedt","year":"2006","unstructured":"Schjoedt K, Rossing K, Juhl T, Boomsma F, Tarnow L, Rossing P et al (2006) Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. Kidney Int 70:536\u2013542","journal-title":"Kidney Int"},{"key":"15_CR84","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1038\/sj.ki.5000410","volume":"69","author":"S Shankland","year":"2006","unstructured":"Shankland S (2006) The podocyte\u2019s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int 69:2131\u20132147","journal-title":"Kidney Int"},{"key":"15_CR85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.yexcr.2016.06.009","volume":"346","author":"L Sheng","year":"2016","unstructured":"Sheng L, Yang M, Ding W, Zhang M, Niu J, Qiao Z et al (2016) Epidermal growth factor receptor signaling mediates aldosterone-induced profibrotic responses in kidney. Exp Cell Res 346:99\u2013110","journal-title":"Exp Cell Res"},{"key":"15_CR86","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T (2007) Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1. Hypertension 49:355\u2013364","journal-title":"Hypertension"},{"key":"15_CR87","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/nm.1879","volume":"14","author":"S Shibata","year":"2008","unstructured":"Shibata S, Nagase M, Yoshida S, Kawarazaki W, Kurihara H, Tanaka H et al (2008) Modification of mineralocorticoid receptor function by Rac1 GTPase: implication in proteinuric kidney disease. Nat Med 14:1370\u20131376","journal-title":"Nat Med"},{"issue":"333\u2013335","key":"15_CR88","first-page":"3","volume":"9","author":"S Simpson","year":"1953","unstructured":"Simpson S (1953) Isolation from the adrenals of a new crystalline hormone with especially high effectiveness on mineral metabolism. Experientia 9(333\u2013335):3","journal-title":"Experientia"},{"key":"15_CR89","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00030.2003","volume":"84","author":"A Spat","year":"2004","unstructured":"Spat A, Hunyady L (2004) Control of aldosterone secretion: a model for convergence in cellular signaling pathways. Physiol Rev 84:489\u2013539","journal-title":"Physiol Rev"},{"key":"15_CR90","doi-asserted-by":"publisher","first-page":"F520","DOI":"10.1152\/ajprenal.00570.2012","volume":"305","author":"M Su","year":"2013","unstructured":"Su M, Dhoopun A-R, Yuan Y, Huang S, Zhu C, Ding G et al (2013) Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury. Am J Physiol Renal Physiol 305:F520\u2013F531","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR91","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1161\/01.HYP.35.5.1078","volume":"35","author":"Y Sun","year":"2000","unstructured":"Sun Y, Zhang J, Zhang JQ, Ramires FJ (2000) Local angiotensin II and transforming growth factor-\u03b21 in renal fibrosis of rats. Hypertension 35:1078\u20131084","journal-title":"Hypertension"},{"key":"15_CR92","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s10157-011-0498-x","volume":"16","author":"Y Terada","year":"2012","unstructured":"Terada Y, Ueda S, Hamada K, Shimamura Y, Ogata K, Inoue K et al (2012) Aldosterone stimulates nuclear factor-kappa B activity and transcription of intercellular adhesion molecule-1 and connective tissue growth factor in rat mesangial cells via serum-and glucocorticoid-inducible protein kinase-1. Clin Exp Nephrol 16:81\u201388","journal-title":"Clin Exp Nephrol"},{"key":"15_CR93","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nrc822","volume":"2","author":"JP Thiery","year":"2002","unstructured":"Thiery JP (2002) Epithelial\u2013mesenchymal transitions in tumour progression. Nat Rev Cancer 2:442\u2013454","journal-title":"Nat Rev Cancer"},{"key":"15_CR94","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1097\/01.ju.0000140445.82949.54","volume":"172","author":"H Trachtman","year":"2004","unstructured":"Trachtman H, Weiser AC, Valderrama E, Morgado M, Palmer LS (2004) Prevention of renal fibrosis by spironolactone in mice with complete unilateral ureteral obstruction. J Urol 172:1590\u20131594","journal-title":"J Urol"},{"key":"15_CR95","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1093\/eurheartj\/ehr253","volume":"32","author":"T Unger","year":"2011","unstructured":"Unger T, Paulis L, Sica DA (2011) Therapeutic perspectives in hypertension: novel means for renin\u2013angiotensin\u2013aldosterone system modulation and emerging device-based approaches. Eur Heart J 32:2739\u20132747","journal-title":"Eur Heart J"},{"key":"15_CR96","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/eurheartj\/15.suppl_D.68","volume":"15","author":"H Urata","year":"1994","unstructured":"Urata H, Hoffmann S, Ganten D (1994a) Tissue angiotensin II system in the human heart. Eur Heart J 15:68\u201378","journal-title":"Eur Heart J"},{"key":"15_CR97","first-page":"S17","volume":"12","author":"H Urata","year":"1994","unstructured":"Urata H, Strobel F, Ganten D (1994b) Widespread tissue distribution of human chymase. J Hypertens Suppl 12:S17\u2013S22","journal-title":"J Hypertens Suppl"},{"key":"15_CR98","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"H Wang","year":"2016","unstructured":"Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A et al (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388:1459\u20131544","journal-title":"Lancet"},{"key":"15_CR99","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1124\/jpet.116.236463","volume":"359","author":"SM Weldon","year":"2016","unstructured":"Weldon SM, Cerny MA, Gueneva-Boucheva K, Cogan D, Guo X, Moss N et al (2016) Selectivity of BI 689648, a novel, highly selective aldosterone synthase inhibitor: comparison with FAD286 and LCI699 in nonhuman primates. J Pharmacol Exp Ther 359:142\u2013150","journal-title":"J Pharmacol Exp Ther"},{"key":"15_CR100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10741-005-2343-3","volume":"10","author":"GH Williams","year":"2005","unstructured":"Williams GH (2005) Aldosterone biosynthesis, regulation, and classical mechanism of action. Heart Fail Rev 10:7\u201313","journal-title":"Heart Fail Rev"},{"key":"15_CR101","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1210\/jc.2003-030490","volume":"88","author":"JS Williams","year":"2003","unstructured":"Williams JS, Williams GH (2003) 50th anniversary of aldosterone. J Clin Endocrinol Metab 88:2364\u20132372","journal-title":"J Clin Endocrinol Metab"},{"key":"15_CR102","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","volume":"54","author":"G Wolf","year":"2005","unstructured":"Wolf G, Chen S, Ziyadeh FN (2005) From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy. Diabetes 54:1626\u20131634","journal-title":"Diabetes"},{"key":"15_CR103","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/cvr\/cvn064","volume":"79","author":"M Yamada","year":"2008","unstructured":"Yamada M, Kushibiki M, Osanai T, Tomita H, Okumura K (2008) Vasoconstrictor effect of aldosterone via angiotensin II type 1 (AT1) receptor: possible role of AT1 receptor dimerization. Cardiovasc Res 79:169\u2013178","journal-title":"Cardiovasc Res"},{"key":"15_CR104","first-page":"180","volume":"40","author":"J Yuan","year":"2007","unstructured":"Yuan J, Jia R, Bao Y (2007) Aldosterone up-regulates production of plasminogen activator inhibitor-1 by renal mesangial cells. J Biochem Mol Biol 40:180\u2013188","journal-title":"J Biochem Mol Biol"},{"key":"15_CR105","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/ki.2012.188","volume":"82","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Huang S, Wang W, Wang Y, Zhang P, Zhu C et al (2012a) Activation of peroxisome proliferator-activated receptor-\u03b3 coactivator 1\u03b1 ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury. Kidney Int 82:771\u2013789","journal-title":"Kidney Int"},{"key":"15_CR106","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.freeradbiomed.2012.03.015","volume":"53","author":"Y Yuan","year":"2012","unstructured":"Yuan Y, Chen Y, Zhang P, Huang S, Zhu C, Ding G et al (2012b) Mitochondrial dysfunction accounts for aldosterone-induced epithelial-to-mesenchymal transition of renal proximal tubular epithelial cells. Free Radic Biol Med 53:30\u201343","journal-title":"Free Radic Biol Med"},{"key":"15_CR107","doi-asserted-by":"publisher","first-page":"F798","DOI":"10.1152\/ajprenal.00055.2017","volume":"314","author":"Y Yuan","year":"2017","unstructured":"Yuan Y, Zhang A, Qi J, Wang H, Liu X, Zhao M et al (2017) P53\/Drp1-dependent mitochondrial fission mediates aldosterone-induced podocyte injury and mitochondrial dysfunction. Am J Physiol Renal Physiol 314:F798\u2013F808","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR108","doi-asserted-by":"publisher","first-page":"F723","DOI":"10.1152\/ajprenal.00480.2006","volume":"293","author":"A Zhang","year":"2007","unstructured":"Zhang A, Jia Z, Guo X, Yang T (2007) Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial origin. Am J Physiol Renal Physiol 293:F723\u2013F731","journal-title":"Am J Physiol Renal Physiol"},{"key":"15_CR109","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/ki.2011.29","volume":"80","author":"A Zhang","year":"2011","unstructured":"Zhang A, Jia Z, Wang N, Tidwell TJ, Yang T (2011) Relative contributions of mitochondria and NADPH oxidase to deoxycorticosterone acetate-salt hypertension in mice. Kidney Int 80:51\u201360","journal-title":"Kidney Int"},{"key":"15_CR110","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1159\/000430291","volume":"36","author":"A Zhang","year":"2015","unstructured":"Zhang A, Han Y, Wang B, Li S, Gan W (2015) Beyond gap junction channel function: the expression of Cx43 contributes to aldosterone-induced mesangial cell proliferation via the ERK1\/2 and PKC pathways. Cell Physiol Biochem 36:1210\u20131222","journal-title":"Cell Physiol Biochem"},{"key":"15_CR111","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.ajpath.2011.01.029","volume":"178","author":"C Zhu","year":"2011","unstructured":"Zhu C, Huang S, Yuan Y, Ding G, Chen R, Liu B et al (2011) Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPAR\u03b3. Am J Pathol 178:2020\u20132031","journal-title":"Am J Pathol"}],"container-title":["Advances in Experimental Medicine and Biology","Renal Fibrosis: Mechanisms and Therapies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-13-8871-2_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T03:05:19Z","timestamp":1565319919000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-13-8871-2_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9789811388705","9789811388712"],"references-count":111,"URL":"https:\/\/doi.org\/10.1007\/978-981-13-8871-2_15","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"9 August 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}